{
  "id": "everyday#management_ebbd62e4",
  "title_en": "General — Management",
  "title_vi": "General — Management",
  "text_en": "xxviii DSM-5 Classification 305.90 (F16.10) Mild 304.60 (F16.20) Moderate 304.60 (F16.20) Severe ___.__ (___.__) Other Hallucinogen Use Disordera, b (246) Specify the particular hallucinogen Specify current severity: 305.30 (F16.10) Mild 304.50 (F16.20) Moderate 304.50 (F16.20) Severe 292.89 (___.__) Phencyclidine Intoxication (248) (F16.129) With use disorder, mild (F16.229) With use disorder, moderate or severe (F16.929) Without use disorder 292.89 (___.__) Other Hallucinogen Intoxication (249) (F16.129) With use disorder, mild (F16.229) With use disorder, moderate or severe (F16.929) Without use disorder 292.89 (F16.983)Hallucinogen Persisting Perception Disorder (250) ___.__ (___.__) Other Phencyclidine-Induced Disorders (251) ___.__ (___.__) Other Hallucinogen-Induced Disorders (251) 292.9 (F16.99) Unspecified Phencyclidine-Related Disorder (252) 292.9 (F16.99) Unspecified Hallucinogen-Related Disorder (252) Inhalant-Related Disorders (252) ___.__ (___.__) Inhalant Use Disordera, b (252) Specify the particular inhalant Specify current severity: 305.90 (F18.10) Mild 304.60 (F18.20) Moderate 304.60 (F18.20) Severe 292.89 (___.__) Inhalant Intoxication (254) (F18.129) With use disorder, mild (F18.229) With use disorder, moderate or severe (F18.929) Without use disorder DSM-5 Classification xxix ___.__ (___.__) Other Inhalant-Induced Disorders (255) 292.9 (F18.99) Unspecified Inhalant-Related Disorder (256) Opioid-Related Disorders (256) ___.__ (___.__) Opioid Use Disordera (256) Specify if: On maintenance therapy, In a controlled environment Specify current severity: 305.50 (F11.10) Mild 304.00 (F11.20) Moderate 304.00 (F11.20) Severe 292.89 (___.__) Opioid Intoxicationc (258) Without perceptual disturbances (F11.129) With use disorder, mild (F11.229) With use disorder, moderate or severe (F11.929) Without use disorder With perceptual disturbances (F11.122) With use disorder, mild (F11.222) With use disorder, moderate or severe (F11.922) Without use disorder 292.0 (F11.23) Opioid Withdrawald (259) ___.__ (___.__) Other Opioid-Induced Disorders (260) 292.9 (F11.99) Unspecified Opioid-Related Disorder (261) Sedative-, Hypnotic-, or Anxiolytic-Related Disorders (261) ___.__ (___.__) Sedative, Hypnotic, or Anxiolytic Use Disordera, b (261) Specify current severity: 305.40 (F13.10) Mild 304.10 (F13.20) Moderate 304.10 (F13.20) Severe 292.89 (___.__) Sedative, Hypnotic, or Anxiolytic Intoxication (264) (F13.129) With use disorder, mild (F13.229) With use disorder, moderate or severe (F13.929) Without use disorder",
  "gloss_vi": "Xxviii dsm-5 classification 305.90 (f16.10) mild 304.60 (f16.20) moderate 304.60 (f16.20) severe ___.__ (___.__) other hallucinogen use disordera, b (246) specify the particular hallucinogen specify current severity: 305...",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "management"
    ],
    "life_topics": [],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Management General — Management xxviii DSM-5 Classification 305.90 (F16.10) Mild 304.60 (F16.20) Moderate 304.60 (F16.20) Severe ___.__ (___.__) Other Hallucinogen Use Disordera, b (246) Specify the particular hallucinogen Specify current severity: 305.30 (F16.10) Mild 304.50 (F16.20) Moderate 304.50 (F16.20) Severe 292.89 (___.__) Phencyclidine Intoxication (248) (F16.129) With use disorder, mild (F16.229) With use disorder, moderate or severe (F16.929) Without use disorder 292.89 (___.__) Other Hallucinogen Intoxication (249) (F16.129) With use disorder, mild (F16.229) With use disorder, moderate or severe (F16.929) Without use disorder 292.89 (F16.983)Hallucinogen Persisting Perception Disorder (250) ___.__ (___.__) Other Phencyclidine-Induced Disorders (251) ___.__ (___.__) Other Hallucinogen-Induced Disorders (251) 292.9 (F16.99) Unspecified Phencyclidine-Related Disorder (252) 292.9 (F16.99) Unspecified Hallucinogen-Related Disorder (252) Inhalant-Related Disorders (252) ___.__ (___.__) Inhalant Use Disordera, b (252) Specify the particular inhalant Specify current severity: 305.90 (F18.10) Mild 304.60 (F18.20) Moderate 304.60 (F18.20) Severe 292.89 (___.__) Inhalant Intoxication (254) (F18.129) With use disorder, mild (F18.229) With use disorder, moderate or severe (F18.929) Without use disorder DSM-5 Classification xxix ___.__ (___.__) Other Inhalant-Induced Disorders (255) 292.9 (F18.99) Unspecified Inhalant-Related Disorder (256) Opioid-Related Disorders (256) ___.__ (___.__) Opioid Use Disordera (256) Specify if: On maintenance therapy, In a controlled environment Specify current severity: 305.50 (F11.10) Mild 304.00 (F11.20) Moderate 304.00 (F11.20) Severe 292.89 (___.__) Opioid Intoxicationc (258) Without perceptual disturbances (F11.129) With use disorder, mild (F11.229) With use disorder, moderate or severe (F11.929) Without use disorder With perceptual disturbances (F11.122) With use disorder, mild (F11.222) With use disorder, moderate or severe (F11.922) Without use disorder 292.0 (F11.23) Opioid Withdrawald (259) ___.__ (___.__) Other Opioid-Induced Disorders (260) 292.9 (F11.99) Unspecified Opioid-Related Disorder (261) Sedative-, Hypnotic-, or Anxiolytic-Related Disorders (261) ___.__ (___.__) Sedative, Hypnotic, or Anxiolytic Use Disordera, b (261) Specify current severity: 305.40 (F13.10) Mild 304.10 (F13.20) Moderate 304.10 (F13.20) Severe 292.89 (___.__) Sedative, Hypnotic, or Anxiolytic Intoxication (264) (F13.129) With use disorder, mild (F13.229) With use disorder, moderate or severe (F13.929) Without use disorder Xxviii dsm-5 classification 305.90 (f16.10) mild 304.60 (f16.20) moderate 304.60 (f16.20) severe ___.__ (___.__) other hallucinogen use disordera, b (246) specify the particular hallucinogen specify current severity: 305..."
}